Multivariate Assessment of Gut Microbiota Composition and Its Correlation with Systemic Inflammation and Metabolic Dysregulation in Patients with Metabolic Syndrome
Keywords:
Gut Microbiota, Metabolic Syndrome, Systemic Inflammation, Dysbiosis, Insulin Resistance, Lipid Metabolism, Multivariate Analysis, Chronic InflammationAbstract
Metabolic syndrome (MetS) is a multifactorial disorder marked by visceral obesity, insulin resistance, dyslipidemia, and chronic low-grade inflammation. Recent evidence points to gut microbiota as a critical determinant in the development and progression of MetS. This paper provides a multivariate assessment of gut microbial composition in relation to systemic inflammation and metabolic imbalance in MetS patients. We explore mechanisms linking microbial shifts to metabolic and inflammatory pathways using published data before 2024. The paper also emphasizes potential diagnostic and therapeutic targets within gut microbial ecology.
References
[1] Zhou, S., et al. "Gut microbiota-driven systemic inflammation in metabolic syndrome: mechanisms and diagnostic markers." mSphere, 2023.
[2] Dong, Y., et al. "Microbiota–immune dynamics in metabolic syndrome: a systems biology approach." Journal of Clinical Microbiology, 2023.
[3] Karagounis, L. G., and A. Kassis. "Aging, lifestyle, and gut microbiota: implications for metabolic health." Frontiers in Nutrition, 2023.
[4] Bezirtzoglou, E., et al. "Circadian disruption alters gut microbiome and promotes metabolic dysfunction." Frontiers in Microbiology, 2023.
[5] Kordahi, M. C., et al. "Mucus-penetrating microbiota and low-grade inflammation in metabolic syndrome." Gut Microbes, 2023.
[6] Jin, J., et al. "Microbial prediction models for metabolic dysfunction." Best Practice & Research Clinical Endocrinology & Metabolism, 2023.
[7] Bernabé, B. P., et al. "Intermittent fasting and gut microbiota in obesity-related inflammation." Endocrinology and Metabolism Clinics, 2023.
[8] Ryan, N., et al. "The impact of Bifidobacterium longum BL21 on inflammation and metabolic parameters in PCOS." PLOS ONE, 2023.
[9] Mu, X., et al. "Gut microbiota as a mediator of cardiovascular and metabolic disorders via the NLRP3 inflammasome pathway." The Microbe, vol. 1, 2023.
[10] Bernabé, B. P., et al. "The gut–brain–ovary axis in polycystic ovary syndrome: metabolic and inflammatory interplay." mSphere, vol. 8, no. 3, 2023.
[11] Oliveira, M. L., et al. "Intermittent fasting and metabolic inflammation: microbial and endocrine cross-talk." Endocrinology and Metabolism Clinics, vol. 52, no. 1, 2023, pp. 129–144.
[12] Wang, J., et al. "Roles of extracellular vesicles from various sources in metabolic-associated fatty liver disease." Frontiers in Immunology, vol. 14, 2023.
[13] Liu, Y., et al. "Intestinal alkaline phosphatase as a protective agent in NAFLD via gut microbiome regulation." bioRxiv, preprint, 2023.
[14] Inčiūraitė, R., et al. "Evaluation of polyphenols in modulating intestinal inflammation in metabolic diseases." Journal of Crohn's and Colitis, vol. 19, suppl. 1, 2023, pp. i438–i445.
[15] Kaur, N., et al. "Antibiotic-induced gut dysbiosis and its cardiovascular implications: the gut–heart axis." Molecular Biology Reports, vol. 50, no. 1, 2023, pp. 67–78.
Downloads
Published
Issue
Section
License
Copyright (c) -1 Mirac A. Inanici (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
